Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Mortality in patients with septic shock correlates with anti-inflammatory but not proinflammatory immunomodulatory molecules.

de Pablo R, Monserrat J, Reyes E, Diaz-Martin D, Rodriguez Zapata M, Carballo F, de la Hera A, Prieto A, Alvarez-Mon M.

J Intensive Care Med. 2011 Mar-Apr;26(2):125-32. doi: 10.1177/0885066610384465.

PMID:
21464065
2.

Anti-inflammatory cytokine levels in patients with septic shock.

Kasai T, Inada K, Takakuwa T, Yamada Y, Inoue Y, Shimamura T, Taniguchi S, Sato S, Wakabayashi G, Endo S.

Res Commun Mol Pathol Pharmacol. 1997 Oct;98(1):34-42.

PMID:
9434313
3.

Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock.

Tamayo E, Fernández A, Almansa R, Carrasco E, Heredia M, Lajo C, Goncalves L, Gómez-Herreras JI, de Lejarazu RO, Bermejo-Martin JF.

Eur Cytokine Netw. 2011 Jun;22(2):82-7. doi: 10.1684/ecn.2011.0281.

4.

Circulating endothelin-1 and tumor necrosis factor-alpha: early predictors of mortality in patients with septic shock.

Brauner JS, Rohde LE, Clausell N.

Intensive Care Med. 2000 Mar;26(3):305-13.

PMID:
10823387
5.

Gastric mucosal acidosis and cytokine release in patients with septic shock.

Tamion F, Richard V, Sauger F, Menard JF, Girault C, Richard JC, Thuillez C, Leroy J, Bonmarchand G.

Crit Care Med. 2003 Aug;31(8):2137-43.

PMID:
12973171
6.

Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis.

Riché FC, Cholley BP, Panis YH, Laisné MJ, Briard CG, Graulet AM, Guéris JL, Valleur PD.

Crit Care Med. 2000 Feb;28(2):433-7.

PMID:
10708179
7.

Health-related quality of life is related to cytokine levels at 12 months in patients with chronic heart failure.

Mommersteeg PM, Kupper N, Schoormans D, Emons W, Pedersen SS.

Brain Behav Immun. 2010 May;24(4):615-22. doi: 10.1016/j.bbi.2010.01.004. Epub 2010 Jan 13.

PMID:
20074634
9.

Elevated serum levels of the type I and type II receptors for tumor necrosis factor-alpha as predictive factors for ARF in patients with septic shock.

Iglesias J, Marik PE, Levine JS; Norasept II Study Investigators.

Am J Kidney Dis. 2003 Jan;41(1):62-75.

PMID:
12500222
10.
11.

Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma.

Martin C, Boisson C, Haccoun M, Thomachot L, Mege JL.

Crit Care Med. 1997 Nov;25(11):1813-9.

PMID:
9366763
12.

Immunological status of septic and trauma patients. I. High tumor necrosis factor alpha serum levels in septic and trauma patients are not responsible for increased mortality; a prognostic value of serum interleukin 6.

Adamik B, Zimecki M, Właszczyk A, Kübler A.

Arch Immunol Ther Exp (Warsz). 1997;45(2-3):169-75. Erratum in: Arch Immunol Ther Exp (Warsz) 1997;45(4):350.

PMID:
9597083
13.

The effect of aging on circulating levels of proinflammatory cytokines during septic shock. Norasept II Study Investigators.

Marik PE, Zaloga GP; NORASEPT II Study Investigators. North American Sepsis Trial II.

J Am Geriatr Soc. 2001 Jan;49(1):5-9.

PMID:
11207836
14.

Influence of innate cytokine production capacity on clinical manifestation and severity of pediatric meningococcal disease.

Sprong T, van der Ven-Jongekrijg J, Neeleman C, van der Meer JW, van Deuren M.

Crit Care Med. 2009 Oct;37(10):2812-8. doi: 10.1097/CCM.0b013e3181ab851c.

PMID:
19707127
15.

Usefulness of Type D personality and kidney dysfunction as predictors of interpatient variability in inflammatory activation in chronic heart failure.

Denollet J, Schiffer AA, Kwaijtaal M, Hooijkaas H, Hendriks EH, Widdershoven JW, Kupper N.

Am J Cardiol. 2009 Feb 1;103(3):399-404. doi: 10.1016/j.amjcard.2008.09.096. Epub 2008 Nov 21.

PMID:
19166697
16.

Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients.

Abraham E, Laterre PF, Garbino J, Pingleton S, Butler T, Dugernier T, Margolis B, Kudsk K, Zimmerli W, Anderson P, Reynaert M, Lew D, Lesslauer W, Passe S, Cooper P, Burdeska A, Modi M, Leighton A, Salgo M, Van der Auwera P; Lenercept Study Group.

Crit Care Med. 2001 Mar;29(3):503-10.

PMID:
11373411
17.
18.

High tumor necrosis factor serum level is associated with increased survival in patients with abdominal septic shock: a prospective study in 59 patients.

Riché F, Panis Y, Laisné MJ, Briard C, Cholley B, Bernard-Poenaru O, Graulet AM, Guéris J, Valleur P.

Surgery. 1996 Nov;120(5):801-7.

PMID:
8909514
19.

[Significance of serum concentrations of pro- and anti-inflammatory cytokines in identification of patients with Crohn's disease].

Kohut M, Hartleb M, Hartleb T.

Pol Merkur Lekarski. 2010 Sep;29(171):169-72. Polish.

PMID:
20931826
20.

Evidence for the participation of soluble triggering receptor expressed on myeloid cells-1 in the systemic inflammatory response syndrome after multiple trauma.

Giamarellos-Bourboulis EJ, Mouktaroudi M, Tsaganos T, Koutoukas P, Spyridaki E, Pelekanou A, Kotzampassi K.

J Trauma. 2008 Dec;65(6):1385-90. doi: 10.1097/TA.0b013e31814699cc.

PMID:
19077631

Supplemental Content

Support Center